SLGL - Sol-Gel Technologies Ltd. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

SLGL

SOL-GEL TECHNOLOGIES LTD.

NASDAQ

$68.81

▼ DOWN 5.18% (-3.76)

KEY STATISTICS

Market Cap$224.94 M

52w High$97.97

52w Low$22.04

Dividend Yield—

Frequency—

P/E-12.20

Volume147.79K

Shares Out.3.27M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Moshe Arkin

ABOUT

SECTOR

Healthcare

WENT PUBLIC

February 1, 2018

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

PRICE TARGET

Target High$110.00

Target Low$110.00

Target Median$110.00

Target Consensus$110.00

UPCOMING EARNINGS

DateNov 19, 2026

DayThursday

Rev. Est.$100.00K

NOV

THU

SPLIT RECORD

DATE	TYPE	RATIO
2025-05-05	Reverse	1:10

PRICE

$68.81 ▼ DOWN 5.18% (−$3.76)

OVERLAYS

About Sol-Gel Technologies Ltd.

https://www.sol-gel.com ↗

Sol-Gel Technologies Ltd. is an Israel-based clinical-stage pharma company developing proprietary microencapsulation-based topical dermatological products, with lead candidates in Phase III for acne and rosacea and collaborations like Perrigo.

INDUSTRY

Biotechnology

A PRODUCT SOL-GEL TECHNOLOGIES LTD. IS KNOWN FOR

SGT-610 (patidegib gel, 2%)

A Phase III topical gel aimed at preventing new basal cell carcinoma lesions in Gorlin syndrome patients, serving as the company's primary focus and most advanced pipeline candidate.

COMPETITORS

COMPETITOR

Revenue by Products

Icon	PRODUCT	Q2-2022	Q4-2022
	License	$3.52M	$365K ▼
	Collabrations	$0	—

Revenue by Geography

REGION	FY2024	FY2025
UNITED STATES	—	$16.7M
ISRAEL	$3.81M	—
CANADA	$681K	$1.68M ▲
SWITZERLAND	$1.48M	$711K ▼
Segment Geographical Groups Of Countries Group Five	$691K	$278K ▼
CHINA	$4.87M	$27K ▼